Cayman, Pioneer in Lipid Nanoparticle Research
15 Jun 2026
Lipid nanoparticles (LNPs) now occupy a central role in the development of innovative nucleic acid-based therapies. Used as vectors to deliver therapeutic molecules into cells, they represent a key driver across fields as varied as vaccination, oncology and gene therapy.